You are here

Merck

FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer

Stat

Fri, 06/12/20 - 08:11 pm

head and neck cancer

Merck & Co’s Keytruda fails in first line bladder cancer

Pharmaforum

Wed, 06/10/20 - 10:51 am

The coronavirus vaccine frontrunners have emerged. Here's where they stand

BioPharma Dive

Tue, 06/9/20 - 12:32 pm

Moderna Therapeutics

Cansino Biologics

Oxford BioMedica

Is Moderna Really the Leader in the COVID-19 Vaccine Race?

Motley Fool

Mon, 06/8/20 - 10:36 am

Moderna Therapeutics

Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP

Pharmaceutical Business Review

Mon, 06/8/20 - 10:27 am

hospital-acquired bacterial pneumonia

ventilator-associated bacterial pneumonia

Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support

Motley Fool

Wed, 06/3/20 - 11:39 pm

Operation Warp Speed

Moderna Therapeutics

With protests raging, Merck CEO Frazier urges businesses to help bridge the racial equity gap

Fierce Pharma

Tue, 06/2/20 - 10:21 am

Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.

Fierce Pharma

Mon, 06/1/20 - 11:39 pm

ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data

Fierce Pharma

Mon, 06/1/20 - 12:00 am

clinical trials

ASCO: Merck's Keytruda doubles time to disease progression in certain colorectal cancer patients

Fierce Pharma

Thu, 05/28/20 - 11:10 pm

clinical trials

colorectal cancer

Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year

Stat

Tue, 05/26/20 - 11:00 am

FDA Approves New Prostate Cancer Treatment From AstraZeneca and Merck

Motley Fool

Wed, 05/20/20 - 11:23 pm

prostate cancer

Merck Spinoff Organon Taps Ex-Allergan Execs Walsh, Stahler for C-Suite

Xconomy

Wed, 05/20/20 - 11:20 pm

Cybersecurity, Pharma, and Whistleblowing

CP WIre

Mon, 05/18/20 - 10:41 am

Cybersecurity, Pharma, and Whistleblowing

Fri, 05/15/20 - 03:57 pm

ASCO 2020 – first-line lung cancer focus

EP Vantage

Thu, 05/14/20 - 12:02 pm

Bristol-Myers Squibb

ASCO: Is the PD-1 target behind Keytruda's small-cell miss? Merck exec says no

Fierce Pharma

Wed, 05/13/20 - 10:38 pm

extensive-stage small cell lung cancer

Merck pours $400M into flea drugs for Fido

Endpoints

Wed, 05/13/20 - 11:38 am

Merck doubles down on Skyhawk's tech to drug RNA, promising $600M per autoimmune, metabolic target

Endpoints

Tue, 05/12/20 - 11:55 am

Skyhawk Therapeutics

small molecule drugs

Merck to move global headquarters, returning to an old home

Endpoints

Mon, 05/11/20 - 11:39 pm

Pages